載入...
Development of central nervous system metastases as a first site of metastatic disease in breast cancer patients treated in the neoadjuvant trials GeparQuinto and GeparSixto
BACKGROUND: The incidence of central nervous system (CNS) metastases in breast cancer patients is rising and has become a major clinical challenge. Only few data are published concerning risk factors for the development of CNS metastases as a first site of metastatic disease in breast cancer patient...
Na minha lista:
| 發表在: | Breast Cancer Res |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
BioMed Central
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6509843/ https://ncbi.nlm.nih.gov/pubmed/31077239 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13058-019-1144-x |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|